echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Focusing on the future plans of the pharmaceutical equipment giants, the field of biomedicine will become a "sweet potato"?

    Focusing on the future plans of the pharmaceutical equipment giants, the field of biomedicine will become a "sweet potato"?

    • Last Update: 2021-10-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On September 15th, Chutian Technology disclosed a survey activity information.
    In this survey, Chutian Technology revealed the company’s plan for biopharmaceutical related fields.
    The sales growth rate of process technology and process equipment related to biopharmaceuticals exceeds that of other product lines
    .
    The company is benchmarking Sartorius in the biological field to complement related product series and industrial chains
    .
    At the same time, regarding the current progress of the company’s biopharmaceutical field that the organization is concerned about, the company mentioned that it has planned a single-use reactor, a single-use liquid dispensing system, a single-use storage system (SUT), etc.
    , and the product is planned to be at the end of this year or early next year.
    Listed
    .
    In the future, related products such as biological fillers and culture media will be gradually introduced
    .
    It can be seen that Chutian Technology's future layout in the field of biopharmaceuticals will continue to deepen.
    In addition to Chutian Technology, in fact, Tofflon also revealed during the investigation of institutions that the preparation of biomedical solutions and the output of engineering capabilities will be the future of China.
    Even on the track where the demand for the global innovative drug market is growing rapidly, Tofflon will form a team to meet the needs of the domestic and foreign markets
    .
    In addition, Canaan Technology also plans to focus on the development of pharmaceutical liquid dispensing systems, intelligent logistics systems and pharmaceutical R&D services for innovative biological drugs
    .
    Canaan Technology believes that the rapid development of the biopharmaceutical industry will bring more business opportunities to the company
    .
    Focusing on the future plans of the pharmaceutical equipment giants, the field of biopharmaceuticals seems to have become a sweet pastry
    .
    Behind these giants' marching into the field of biopharmaceuticals, the industry believes that they are looking at the broad development prospects of the biopharmaceutical market
    .
    So, how big is the biopharmaceutical market? Biological drugs are macromolecular drugs, mainly including monoclonal antibodies, double antibodies, ADC drugs, cell therapy, stem cells, gene therapy, etc.
    The production technology is more complex than chemical drugs, and the technical barriers are relatively high
    .
    In recent years, with the strong support of national policies, the intensified population aging, the increase in per capita disposable income, and the industry’s technological innovation, my country’s biopharmaceutical industry has maintained rapid development and the market scale has continued to expand.
    It has grown from 1836 in 2016.
    Billion yuan to 345.
    7 billion yuan in 2020, the industry expects that the market will continue to grow, reaching 424.
    8 billion yuan in 2021
    .
    In the face of a considerable market, biopharmaceuticals have become the new darling of the capital market, and the enthusiasm of pharmaceutical companies continues to rise, attracting many chemical, Chinese patent medicine, and raw material pharmaceutical companies to switch tracks and enter the field
    .
    The industry pointed out that at present, China's biopharmaceutical market is mainly imported products.
    With the acceleration of the integration of biopharmaceuticals into centralized procurement, innovation will be further promoted, and there is huge room for domestic penetration to increase
    .
    In addition, competition in the biopharmaceutical market will also become fierce in the future.
    According to an industry research survey, more than 70% of respondents in the biopharmaceutical industry indicated that they will increase investment in new technologies and processes in manufacturing, especially in Chinese market
    .
    It is foreseeable that in the process of increasing investment in the industry, upstream biopharmaceutical-related equipment will also usher in a new round of opportunities, and demand will continue to grow.
    It is expected that pharmaceutical companies that have advanced in the field of high-end equipment will gain development opportunities
    .
    It is worth mentioning that the technical threshold of biopharmaceutical equipment is high and manufacturing is difficult, and the domestic market has always been monopolized by foreign-funded enterprises
    .
    Therefore, while seeing opportunities, domestic enterprises also need to continuously increase R&D investment, gradually break the import monopoly, realize the substitution of imported products, and help China's biopharmaceutical industry to develop better
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.